PTC THERAPEUTICS INC - NOTE 1.500% 9/1

Historical Holders from Q2 2022 to Q3 2025

Type / Class
Debt / NOTE 1.500% 9/1
All holders as of 30 Sep 2025
Q3 2025
Total 13F principal, excl. options
278,232,000
Holdings value
$296,027,478
% of all portfolios
0%
Number of holders
15
Number of buys
3
Number of sells
-5
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of PTC THERAPEUTICS INC - NOTE 1.500% 9/1

Period Principal Value Change Price Investors
2025 Q3 278,232,000 $296,027,478 +$725,502 $1.28 15
2025 Q2 275,383,000 $318,055,093 -$3,252,102 $1.15 15
2025 Q1 276,612,000 $326,799,984 +$764,592 $1.17 14
2024 Q4 264,421,591 $309,275,303 -$20,168,580 $1.12 13
2024 Q3 259,449,591 $309,774,451 +$582,114 $1.04 12
2024 Q2 259,449,591 $284,800,544 +$182,994 $0.954 12
2024 Q1 274,717,308 $277,129,832 -$20,916,765,749 $0.9325 14
2023 Q4 287,509,503 $273,105,852 +$15,160,001 $0.9188 14
2023 Q3 278,652,272 $229,332,855 -$3,058,195 $0.797 20
2023 Q2 287,637,000 $296,005,222 -$2,491,781 $1.03 19
2023 Q1 279,704,527 $327,735,385 +$7,856,990 $1.14 17
2022 Q4 287,400,000 $284,218,480 -$1,258,207 $0.9854 10
2022 Q3 287,600,000 $336,226,000 +$32,736,045 $1.17 11
2022 Q2 262,509,000 $275,443,000 +$275,443,000 $1.05 10